New Regulation on Academic Promotion, Proliferation of our Cardiology Journals and the Past Year of the Archives of TSC [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2002; 30(12): 735-736

New Regulation on Academic Promotion, Proliferation of our Cardiology Journals and the Past Year of the Archives of TSC

Altan ONAT1

Pulmonary hypertension secondary to pulmonary histiocytosis X is a progressive disease and has a poor prognosis. Despite conventional treatments (immunosuppresive agents, calcium channel blockers and continious O2 therapies) symptomatic improvement may not be seen. We found that single dose iloprost inhalation and oral sildenafil citrate treatment decreased pulmonary artery pressure in a patient with pulmonary hypertension secondary to histiocytosis X whose functional capacity was NYHA class IV. After one week of treatment period, functional capacity and six minutes walking test were improved with this combination. Combination of iloprost inhalation and oral sildenafil citrate might be an effective treatment options in pulmonary hypertension secondary to histiocytosis X.


How to cite this article
Altan ONAT. New Regulation on Academic Promotion, Proliferation of our Cardiology Journals and the Past Year of the Archives of TSC. Turk Kardiyol Dern Ars. 2002; 30(12): 735-736
Manuscript Language: Turkish
© Copyright 2022 Archives of the Turkish Society of Cardiology
LookUs & Online Makale